Results from a phase II trial of pembrolizumab (P) plus gemcitabine (Gem) in patients (pts) with HER2-negative advanced breast cancer (ABC): GEICAM/2015-04 (PANGEA-Breast) study
Por:
de la Cruz-Merino, L, Cruz, J, Alonso, JL, Garcia, VQ, Anton, FM, Andres, R, Santiesteban, M, Vazquez, MR, Cortes, MG, Cortes, J, Carrion, NP, Lenza, IC, Soto, A, Casas, M, Benito, S, Montes, SB and Holgado, E
Publicada:
1 dic 2019
Resumen:
Filiaciones:
de la Cruz-Merino, L:
Hosp Univ Virgen Macarena, Med Oncol, Seville, Spain
Cruz, J:
Hosp Univ Canarias, Med Oncol, Santa Cruz De Tenerife, Spain
Alonso, JL:
IMIB Hosp Clin Univ Virgen de la Arrixaca, Med Oncol, Murcia, Spain
:
Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol ICO Badalona, Badalona Appl Res Grp Oncol B ARGO Grp, Med Oncol, Badalona, Spain
Anton, FM:
Hosp Clin Univ San Carlos, Med Oncol, Madrid, Spain
Andres, R:
Hosp Clin Univ Lozano Blesa, Med Oncol, Zaragoza, Spain
Santiesteban, M:
Clin Univ Navarra, Med Oncol, Pamplona, Spain
Vazquez, MR:
Ctr Oncol Galicia, Med Oncol, La Coruna, Spain
Cortes, MG:
Hosp Univ Ramon & Cajal, Med Oncol, Madrid, Spain
Cortes, J:
IOB Inst Oncol, Med Oncol, Barcelona, Spain
Vall dHebron Inst Oncol, Barcelona, Spain
Carrion, NP:
Hosp Univ Virgen Macarena, Clin Oncol, Seville, Spain
Lenza, IC:
Hosp Univ Canarias, Oncol, San Cristobal De Laguna, Spain
Soto, A:
Hosp Clin Univ Virgen de la Arrixaca, Med Oncol, El Palmar, Spain
Casas, M:
GEICAM Spanish Breast Canc Grp, Stat, San Sebastian De Reyes, Spain
Benito, S:
GEICAM Spanish Breast Canc Res Grp, Clin Operat, San Sebastian De Reyes, Spain
Montes, SB:
GEICAM, Dept Sci, Madrid, Spain
Holgado, E:
Hosp Ruber Juan Bravo, IOB Inst Oncol, Med Oncolgoy, Madrid, Spain
|